ANZCHOG Children’s Cancer Clinical Trials Repository

Study Title
ZERO2: Precision Medicine for Every Child With Cancer
Protocol ID
ZERO2
Condition/s
All paediatric cancer types
Diagnosis Stage
Newly diagnosed
Relapsed/Refractory
Location
NSW, QLD, VIC, WA, SA, NZ, TAS
Sponsor
Australian & New Zealand Children's Haematology/Oncology Group
Collaborators
Sydney Children's Hospitals Network
Trial Status
Open
Sites
The Children's Hospital at Westmead
Sydney Children's Hospital
Queensland Children's Hospital
Women's & Children's Hospital
John Hunter Children's Hospital
Royal Hobart Hospital
Monash Children's Hospital
The Royal Children's Hospital
Perth Children's Hospital
Starship Children's Hospital
Christchurch Children's Hospital
Study Type
Observational
Phase
Not applicable
Age Eligibility
0 Years to 25 Years
International registry ID's
NCT05504772
Back to Registry
Study Title ZERO2: Precision Medicine for Every Child With Cancer
Protocol ID ZERO2
Disease (Sub Disease) All paediatric cancer types
Diagnosis Stage Newly diagnosed
Relapsed/Refractory
Location NSW / QLD / VIC / WA / SA / NZ / TAS
Sponsor Australian & New Zealand Children's Haematology/Oncology Group
Collaborators Sydney Children's Hospitals Network
Links https://clinicaltrials.gov/ct2/show/NCT05504772
Trial Status Open
Trial Open Date 16/12/2022
Sites The Children's Hospital at Westmead / Sydney Children's Hospital / Queensland Children's Hospital / Women's & Children's Hospital / John Hunter Children's Hospital/ Royal Hobart Hospital/ Monash Children's Hospital/ The Royal Children's Hospital/ Perth Children's Hospital/ Starship Children's Hospital/ Christchurch Children's Hospital
Study Type Observational
Phase Not applicable
Age Eligibility 0 Years to 25 Years
International registry ID's NCT05504772

Join our newsletter

"*" indicates required fields

This field is for validation purposes and should be left unchanged.

Email info@anzchog.org   |  

Level 6, TRF Building, Hudson Institute, 27-31 Wright St, Clayton VIC 3168